Artificial Cells Nanomedicine and Biotechnology

Papers
(The H4-Index of Artificial Cells Nanomedicine and Biotechnology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Statement of Retraction: Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis151
Correction48
Retraction Statement: Long non-coding RNA UCA1 relieves cardiomyocytes H9c2 injury aroused by oxygen-glucose deprivation via declining miR-1238
Statement of Retraction35
Statement of Retraction32
Expression of Concern32
PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer26
Statement of Retraction25
Correction23
Therapeutic ultrasound treatment for the prevention of chronic kidney disease-associated muscle wasting in mice20
Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells19
Exploring fibroblast interactions on nanocrystalline surfaces in physiological environments through a phenomenological lens19
Evaluation of tenofovir disoproxil fumarate loaded silver nanoparticle on testicular morphology in experimental type-2 diabetic rats19
Synthesis and characterization of Fe 3 O 4 @SiO 2 @PDA@Ag core–shell nanoparticles and biologic19
Oxidative stress and histopathological changes in several organs of mice injected with biogenic silver nanoparticles19
Correction17
Nano-haemoglobin-based oxygen carrier increases the radiosensitivity of non-small-cell lung cancer17
0.1759021282196